Diagnosticos da America revenue and financials

DASA3 · B3 · BRL

R$4.37+6.85%+R$0.28

Close · October 6, 2026

In the fiscal year ended December 2025, Diagnosticos da America reported revenue of R$11.17B (−27.10% year over year). The net loss was R$1.15B.

Annual revenue · 2025: R$11.17B
  1. R$10.42B2021
  2. R$13.13B2022
  3. R$14.25B2023
  4. R$15.32B2024
  5. R$11.17B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−27.10%
2025 vs 2024
Net margin
-10.3%
2024: -7.8%

Financial data

Amounts in millions of BRL; per-share values in BRL; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue2,2242,2232,2702,6082,4663,8263,6693,9693,9563,728—3,769
Cost of revenue1,6031,4771,6261,7271,7342,6912,8232,8272,8162,663—2,655
Gross profit6217456448827321,1358461,1421,1401,065—1,114
Selling, general and administrative361419534470513747836749818769—792
Operating income239295-2573821483423.8441346303—331
EBIT239295-2573821483423.8441346303—331
EBITDA297428-140499245501204581508459—494
Interest expense246303343354366465408418416447—463
Pre-tax income-76.821.6-71875.6133-104-712-68.6-105-182—-129
Income tax-41.912.3230-21.43066.812118.5-5.1-5.4—53.6
Net income-34.1-1.9-95595.8-179-114-831-87.5-105-176—-181
Net income to common shareholders-34.1-1.9-95595.8-179-114-831-87.5-105-176—-181
Basic EPS-0.03-0.00-0.760.08-0.14-0.09-0.30-0.12-0.14-0.24—-0.24
Diluted EPS-0.03-0.00-0.760.08-0.14-0.09-0.30-0.12-0.14-0.24—-0.24
Average shares (basic)1,2551,2551,2551,2551,2501,2502,756747747747—747
Average shares (diluted)1,2551,2551,2551,2551,2501,2502,756747747747—747